Cryptococcosis in Cats: A Serious Fungal Infection

Cryptococcosis is a fungal infection caused by Cryptococcus neoformans and Cryptococcus gattii, two closely related yeast species with worldwide distribution. It holds the distinction of being the most common systemic fungal infection in cats globally, making it an important condition for every cat owner to understand. Unlike many fungal pathogens restricted to specific climates, Cryptococcus species are found across temperate, subtropical, and tropical regions on every inhabited continent.

"Cryptococcosis is the fungal infection I think about first in cats, especially when I see a cat with chronic nasal signs and that characteristic swelling over the bridge of the nose. The good news is that we have an excellent blood test for it, and most cats with the nasal or skin form respond very well to treatment if we catch it early." — Dr. Sarah Chen, DVM

Cryptococcus neoformans is strongly associated with environments contaminated by bird droppings, particularly from pigeons. The fungus thrives in the nitrogen-rich substrate of accumulated pigeon guano found in urban environments — under bridges, in abandoned buildings, on ledges, and in parks. Cryptococcus gattii has a different ecological niche, being associated with eucalyptus trees and certain other tropical and subtropical tree species. C. gattii was historically considered a tropical organism but gained attention when it emerged in the Pacific Northwest of the United States and British Columbia, Canada, demonstrating that its range is expanding.

Cats become infected by inhaling fungal spores (basidiospores) from contaminated environmental sources. The spores are tiny enough to reach the deepest parts of the respiratory tract and initially colonise the nasal cavity and sinuses. From there, the infection may remain localised to the nasal passages or spread to other body systems. Cryptococcosis is the type of disease that underscores the importance of regular veterinary care for cats, as early detection dramatically affects the outcome.

Cats are the domestic animal most commonly diagnosed with cryptococcosis, with infection rates substantially higher than in dogs. The reasons for this feline predisposition are not entirely understood but are thought to relate to cats' respiratory anatomy, their behaviours, and possibly species-specific differences in immune response to the organism. Cats' natural curiosity and tendency to explore environments where Cryptococcus thrives — gardens, sheds, areas frequented by pigeons — increases their exposure risk.

An important risk factor is immune status. Cats that are positive for Feline Immunodeficiency Virus (FIV) or Feline Leukaemia Virus (FeLV) are at substantially higher risk of developing cryptococcosis, and when they do, the disease tends to be more severe and more difficult to treat. FIV in particular impairs the T-cell immune response that is critical for containing fungal infections. Studies have found that anywhere from 15% to 30% of cats with cryptococcosis are FIV-positive, which is significantly higher than the general feline population prevalence of FIV. For this reason, every cat diagnosed with cryptococcosis should be tested for both FIV and FeLV if their status is not already known.

However, it is crucial to understand that immunocompetent (FIV/FeLV-negative) cats also develop cryptococcosis regularly. The majority of affected cats in most studies are actually FIV and FeLV negative, so this is not exclusively a disease of immunosuppressed cats. Both indoor and outdoor cats can be affected, though outdoor cats with access to environments contaminated by bird droppings or near eucalyptus trees may face higher exposure. Even indoor cats that are otherwise healthy and happy can develop cryptococcosis if spores enter the home environment — on shoes, clothing, or through open windows.

There is no clear breed predisposition for cryptococcosis in cats, and both males and females are affected. The typical age of affected cats ranges widely from young adults to geriatric cats, though there may be a slight peak in middle-aged cats (five to ten years). Siamese cats have been reported as overrepresented in some studies, but this finding is not consistent across all populations. The key takeaway is that any cat — regardless of breed, age, sex, indoor/outdoor status, or known FIV/FeLV status — can develop cryptococcosis.

Cryptococcosis in cats manifests in four main clinical forms, often with overlap between them. The presentation depends on which body systems the fungus has colonised, and a single cat may show signs of more than one form simultaneously. Understanding these different presentations helps owners and veterinarians recognise the infection across its varied disguises.

Nasal (upper respiratory) form — This is the most common presentation, reflecting the initial site of infection through spore inhalation. Affected cats develop chronic sneezing, nasal discharge (which may be clear, mucoid, or blood-tinged), and progressive difficulty breathing through the nose. The hallmark finding is a characteristic firm swelling over the bridge of the nose caused by a mass of fungal granulomatous tissue growing beneath the skin. This creates a distinctive bulging appearance sometimes described as a "Roman nose" that is virtually pathognomonic (uniquely characteristic) of feline cryptococcosis. The swelling is typically non-painful but progressively enlarges if untreated.

Central nervous system (CNS) form — When Cryptococcus spreads from the nasal passages through the cribriform plate to the brain, or reaches the CNS via the bloodstream, neurological signs develop. These can include head tilt, circling, loss of balance (vestibular signs), seizures, disorientation, and behavioural changes such as unusual aggression, hiding, or apparent confusion. CNS cryptococcosis is one of the more serious presentations because the blood-brain barrier limits drug penetration, making treatment more challenging. Cats with CNS involvement may deteriorate rapidly without prompt treatment.

Cutaneous (skin) form — Skin involvement produces firm nodules, papules, or ulcerated lesions that most commonly appear on the head, particularly around the nose, lips, and ears, but can occur anywhere on the body. The lesions may drain a thick discharge and can be mistaken for abscesses, tumours, or other skin conditions. Multiple lesions are common, and new nodules may continue to appear during the course of disease.

Ocular form — Eye involvement can cause inflammation within the eye (uveitis), resulting in changes in iris colour, pupil abnormalities (often dilated pupils that respond poorly to light), cloudiness of the eye, and ultimately vision loss. Chorioretinitis (inflammation of the retina and underlying choroid) can be detected on ophthalmoscopic examination and is sometimes the first clue that leads to a cryptococcosis diagnosis. If you notice any changes in your cat's eyes or vision, alongside other subtle signs of discomfort, prompt veterinary evaluation is essential.

One of the advantages of cryptococcosis compared to many other fungal infections is the availability of an excellent, highly reliable blood test that can confirm the diagnosis quickly and accurately. This test, combined with cytological examination of affected tissues, makes cryptococcosis one of the most straightforward fungal infections to diagnose definitively.

The latex agglutination antigen test (LCAT) — also called the cryptococcal antigen test or CrAg — is the gold standard for diagnosis. This test detects the capsular polysaccharide antigen shed by Cryptococcus organisms into the bloodstream. It is both highly sensitive (greater than 95%) and highly specific, meaning false negatives and false positives are rare. The test provides a quantitative result expressed as a titer (e.g., 1:8, 1:64, 1:1024), with higher titers generally correlating with a larger fungal burden. The antigen test can be performed on blood (serum) or cerebrospinal fluid (CSF), with the latter being particularly useful when CNS involvement is suspected.

Cytology is another rapid and highly useful diagnostic tool. Fine-needle aspirates from nasal masses, skin nodules, or enlarged lymph nodes can be stained and examined under the microscope. Cryptococcus organisms have a distinctive and unmistakable appearance: round to oval yeast cells surrounded by a thick, clear capsule that appears as a prominent halo around the organism. This characteristic capsule is what makes Cryptococcus immediately recognisable on cytology and distinguishes it from other yeasts. The organisms are typically 5-20 micrometres in diameter, and narrow-based budding may be observed.

Fungal culture can confirm the species (C. neoformans vs. C. gattii), which may have implications for treatment selection and prognosis. However, culture results take days to weeks and are rarely needed for initial diagnosis when the antigen test and cytology are available. Additional diagnostics that may be recommended include skull radiographs or CT scan (to assess the extent of nasal disease and check for cribriform plate erosion), thoracic radiographs (to evaluate lung involvement), and FIV/FeLV testing (to assess immune status). A complete blood count and chemistry panel help establish baseline organ function before starting antifungal therapy.

Treatment of feline cryptococcosis requires prolonged oral antifungal therapy, with the specific drug choice depending on the form and severity of disease. The good news is that the majority of cats with nasal and cutaneous cryptococcosis respond well to treatment when diagnosed early, though patience is required — treatment durations measured in months are the norm rather than the exception.

Fluconazole is often the first-choice antifungal for feline cryptococcosis, particularly for nasal, cutaneous, and ocular forms. It is well-absorbed orally, has a favourable side-effect profile in cats, and crucially, penetrates the blood-brain barrier effectively, making it useful even when CNS involvement is suspected or confirmed. The typical dose is 50-100 mg per cat once or twice daily (approximately 5-15 mg/kg). Fluconazole is available as tablets and an oral suspension, facilitating administration to cats of different sizes.

Itraconazole is an effective alternative, often used when fluconazole is not tolerated or when a broader spectrum of antifungal activity is desired. It is typically dosed at 5-10 mg/kg once or twice daily. Itraconazole does not cross the blood-brain barrier as effectively as fluconazole, so it is less ideal for confirmed CNS disease. Side effects can include decreased appetite and, less commonly, liver enzyme elevation. For severe CNS cases or those not responding to azole antifungals alone, amphotericin B may be used initially. Amphotericin B is a potent intravenous antifungal that achieves rapid fungal killing but carries a significant risk of kidney toxicity, requiring careful monitoring. It is typically used as induction therapy for two to four weeks before transitioning to oral azole maintenance.

The duration of treatment is guided by clinical response and, critically, by serial cryptococcal antigen titer monitoring. Titers are typically rechecked every two to three months during treatment. The general rule is to continue antifungal therapy until the antigen titer has declined to zero (negative) or less than 1:2, and then for at least an additional one to two months beyond that point. In practice, this means most cats require three to twelve months or more of treatment. Stopping therapy too early — when the cat looks clinically well but the titer is still positive — is the most common cause of relapse. Some cats with disseminated or CNS disease may require treatment for well over a year.

The prognosis for cats with cryptococcosis varies significantly depending on the form of disease and the cat's underlying immune status. Understanding what to expect helps owners make informed treatment decisions and maintain realistic expectations during what can be a lengthy therapeutic journey.

Nasal and cutaneous forms carry the best prognosis. With appropriate antifungal therapy, the majority of immunocompetent cats with these forms achieve a complete cure. The nasal swelling gradually resolves over weeks to months, nasal discharge clears, and skin lesions heal. Response rates of 60-80% or higher are reported in the veterinary literature for localised disease. However, treatment must be continued for the full recommended duration — many owners see dramatic improvement within the first month and are tempted to discontinue medication, but premature cessation almost invariably leads to relapse.

CNS involvement carries a more guarded prognosis. While some cats with CNS cryptococcosis do respond to treatment and recover, the response rates are lower (approximately 40-60%), treatment duration is longer, and the risk of relapse is higher. Cats that present with severe neurological signs — particularly seizures or rapid neurological deterioration — face the most uncertain outcomes. The key is aggressive early treatment with drugs that cross the blood-brain barrier (fluconazole is preferred) and patience with what may be a very prolonged treatment course.

FIV and FeLV status significantly affects the outcome. FIV-positive cats can still respond to antifungal therapy, but they may require longer treatment courses and face higher relapse rates because their compromised immune system cannot assist as effectively in clearing the infection. FeLV-positive cats generally have the most guarded prognosis, as FeLV causes more profound immunosuppression than FIV and is itself associated with reduced life expectancy regardless of the cryptococcosis.

After completing treatment and achieving a negative antigen titer, long-term monitoring is recommended. Periodic antigen retesting (every three to six months for the first year post-treatment) can detect early relapse before clinical signs recur, allowing prompt retreatment. Most relapses occur within six months of stopping therapy. Cats that remain antigen-negative for twelve months after treatment cessation have a very low risk of future relapse and can generally be considered cured. Throughout the treatment and monitoring period, maintaining your cat's overall health and ensuring a stress-free, enriched indoor environment supports the immune system in fighting the infection.